Literature DB >> 1636515

Spinal MR findings in neurofibromatosis types 1 and 2.

J C Egelhoff1, D J Bates, J S Ross, A D Rothner, B H Cohen.   

Abstract

PURPOSE: To evaluate the frequency and nature of spinal pathology, the frequency of clinically silent lesions, and the potential benefit of screening spinal MR in neurofibromatosis patients. PATIENTS AND METHODS: 28 neurofibromatosis type-1 (NF-1) patients and nine neurofibromatosis type-2 (NF-2) patients were studied with postcontrast spinal MR imaging.
RESULTS: NF-1: One patient had a biopsy-proven low-grade glioma; five patients, intradural, extramedullary masses (N = 23); one patient, extradural masses (N = 2) (neurofibromas); 16 patients had bony abnormalities; and three patients thecal sac abnormalities. NF-2: Five patients demonstrated intramedullary masses (five/eight ependymomas); nine patients, intradural, extramedullary masses (meningiomas, schwannomas); and four patients, bony abnormalities. Eight/10 NF-1 and four/nine NF-2 patients had asymptomatic masses.
CONCLUSION: Intradural disease is common, often asymptomatic, and often presents at a young age in NF-1 and NF-2 patients. Because of the propensity to develop significant asymptomatic as well as symptomatic intradural disease, screening of the entire spine with MR is recommended in both NF-1 and NF-2 patients.

Entities:  

Mesh:

Year:  1992        PMID: 1636515      PMCID: PMC8333575     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  12 in total

1.  Type II neurofibromatosis presenting as quadriceps atrophy.

Authors:  L Grazzi; L Chiapparini; E A Parati; S Giombini; D D'Amico; M Leone; G Bussone
Journal:  Ital J Neurol Sci       Date:  1998-04

2.  Hereditary spinal neurofibromatosis: a rare form of NF1?

Authors:  M Poyhonen; E L Leisti; S Kytölä; J Leisti
Journal:  J Med Genet       Date:  1997-03       Impact factor: 6.318

3.  Hamartoma compress medial and radial nerve in neurofibromatosis type 1.

Authors:  Hui Lu; Qiang Chen; Hui Shen
Journal:  Int J Clin Exp Med       Date:  2015-09-15

Review 4.  Neurofibromatosis type 2.

Authors:  Ashok R Asthagiri; Dilys M Parry; John A Butman; H Jeffrey Kim; Ekaterini T Tsilou; Zhengping Zhuang; Russell R Lonser
Journal:  Lancet       Date:  2009-05-22       Impact factor: 79.321

Review 5.  Spinal deformity in neurofibromatosis type-1: diagnosis and treatment.

Authors:  Athanasios I Tsirikos; Asif Saifuddin; M Hilali Noordeen
Journal:  Eur Spine J       Date:  2005-02-15       Impact factor: 3.134

6.  Familial spinal neurofibromatosis due to a multiexonic NF1 gene deletion.

Authors:  Antonio Pizzuti; Irene Bottillo; Francesca Inzana; Valentina Lanari; Francesca Buttarelli; Isabella Torrente; Anna Teresa Giallonardo; Alessandro De Luca; Bruno Dallapiccola
Journal:  Neurogenetics       Date:  2011-03-02       Impact factor: 2.660

7.  Characterization of spinal findings in children and adults with neurofibromatosis type 1 enrolled in a natural history study using magnetic resonance imaging.

Authors:  Rosa Nguyen; Eva Dombi; Srivandana Akshintala; Andrea Baldwin; Brigitte C Widemann
Journal:  J Neurooncol       Date:  2014-10-08       Impact factor: 4.130

8.  Coexistence of multiple rare spinal abnormalities in type 1 neurofibromatosis: a case report and literature review.

Authors:  Chun-Ming Zhao; Wen-Jie Zhang; Ai-Bing Huang; Qian Chen; Yuan-Long He; Wei Zhang; Hui-Lin Yang
Journal:  Int J Clin Exp Med       Date:  2015-10-15

9.  Giant Solitary Anterior Cervical Canal Neurofibroma: Case Report and Surgical Technique.

Authors:  Olufemi Emmanuel Idowu; Kazeem M Atobatele; Sunday O Soyemi
Journal:  Asian Spine J       Date:  2015-07-28

10.  Multidetector CT with 3-dimensional volume rendering in the evaluation of the spine in patients with Neurofibromatosis type 1: a retrospective review in 73 patients.

Authors:  James Matthew Debnam; Yasser Mm Mahfouz; Leena Ketonen; John M Slopis; Ian E McCutcheon; Nandita Guha-Thakurta
Journal:  Scoliosis       Date:  2014-09-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.